Thierry Guillaudeux
Chief Scientific Officer, Proteostasis Therapeutics (United States).
Companies
- Proteostasis Therapeutics (United States)Chief Scientific Officer Dec 20, 2022 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Proteostasis Therapeutics (United States)0 shares2Jun 30, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 30, 2025Returned to company 217,333 shares of Proteostasis Therapeutics (United States)2
- Jun 25, 2025Granted 23,100 shares of Proteostasis Therapeutics (United States)3
- Jun 23, 2025Shares withheld for tax 47,647 shares at $0.26 of Proteostasis Therapeutics (United States)3
- Jun 23, 2025Exercised options 225,000 shares at $0.36 of Proteostasis Therapeutics (United States)3
- Sep 14, 2023Bought 10,000 shares at $2.00 of Proteostasis Therapeutics (United States)4
- Dec 16, 2022Granted 10,320 shares of Proteostasis Therapeutics (United States)5
- Dec 16, 2022Granted 1,376 shares of Proteostasis Therapeutics (United States)5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jun 25, 2025
- 4SEC EDGARForm 4 filed Sep 15, 2023
- 5SEC EDGARForm 4 filed Dec 20, 2022